BioNJ Legal, Compliance & Regulatory Forum - Implications of Patient Engagement

Dec 5 2018

8:00 AM

Linda Pissott Reig, shareholder and co-chair of the firm's FDA & Biotechnology practice, presented at and was co-chair of the BioNJ Legal, Compliance and Regulatory Forum.

The panel discussed implications of patient engagement and key considerations, including:

applicable statuses and cases that help define legal risk
recent government actions that impact how risk is assessed, managed and minimized
ongoing demand for greater transparency in pharmaceutical and biotech relationships
longstanding expectation that industry support of patient organizations is done in a manner that preserves the organization's independence